Caricamento...
Pulmonary hypertension related to systemic sclerosis: points to consider for clinical trials
There are proven successful approaches to clinical trial design in pulmonary arterial hypertension (PAH), which in turn have led to the licensing of a number of effective therapies. SSc has been included in trials of World Health Organization Group 1 PAH but has been under-represented. Responses in...
Salvato in:
| Pubblicato in: | Rheumatology (Oxford) |
|---|---|
| Autori principali: | , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Oxford University Press
2017
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5850595/ https://ncbi.nlm.nih.gov/pubmed/28992168 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kex197 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|